Carcinoid Syndrome with Carcinoid Heart Disease After First-Line SSA and PRRT Have Failed

Clinical Scenario

This protocol targets patients with aggressive carcinoid syndrome characterised by a high symptom burden — more than four bowel movements per day and/or more than five flushing episodes per day — alongside one or more of: tumour progression, hepatic tumour burden exceeding 50%, and/or carcinoid heart disease (CHD).

>4 bowel movements / day >5 flushing episodes / day Hepatic burden >50% Tumour progression Carcinoid heart disease

Prior Treatment — Goals Not Achieved

First-line dose-escalation of SSA and PRRT (177Lutetium-DOTATATE), and/or telotristat ethyl did not achieve adequate control of refractory CS-associated diarrhoea or sufficient reduction in urinary 5-HIAA (u5-HIAA) levels. This protocol is the structured next step after that failure.

Next-Step Approach (Partial Overview)

Loco-regional liver-directed therapies are central to this step, alongside consideration of surgical evaluation for debulking. The presence of carcinoid heart disease significantly shapes how interventions are sequenced — the complete protocol specifies the required approach when CHD is present.

The primary clinical goal is control of carcinoid syndrome symptoms.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jne.13146

RCS may be divided into either non-aggressive or aggressive, based on symptoms burden (< or ≥4 BM/day, and/or < or ≥5 flushing episodes/day, respectively) together with disease stability (stable or progressive), hepatic burden (< or ≥50% liver involvement), and/or the presence of CHD.

Aggressive: high symptom burden, tumor progression, hepatic tumour burden >50% and/or CHD. Aggressive CS: more than four bowel movements (BM)/day and/or more than five flushing episodes/day.

Loco-regional therapies; consider surgical evaluation for debulking.

Hepatic resection/loco-regional therapies are effective for CS, as mentioned earlier, but not recommended if severe CHD is present; in this situation, valve replacement should be performed prior to surgical debulking/loco-regional interventions.

View source ↗